ADMA logo

ADMA Biologics Inc (ADMA)

$13.63

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ADMA

Market cap

$3.02B

EPS

0.77

P/E ratio

14.8

Price to sales

4.53

Dividend yield

--

Beta

0.651084

Price on ADMA

Previous close

$13.47

Today's open

$13.34

Day's range

$13.12 - $13.66

52 week range

$7.21 - $20.46

Profile about ADMA

CEO

Adam S. Grossman

Employees

647

Headquarters

Ramsey, NJ

Exchange

NASDAQ Global Market

Shares outstanding

221854389

Issue type

Common Stock

ADMA industries and sectors

Healthcare

Biotechnology & Life Sciences

News on ADMA

Here's Why Adma Biologics (ADMA) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Nov 13, 2026

news preview

ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?

ADMA Biologics gains 20.9% after strong Q3 results, as surging Asceniv sales and a raised 2026 profit outlook offset Bivigam weakness and competitive pressures.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Why Adma Biologics (ADMA) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average

From a technical perspective, Adma Biologics (ADMA) is looking like an interesting pick, as it just reached a key level of support. ADMA recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

news source

Zacks Investment Research • Nov 6, 2026

news preview

Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average

After reaching an important support level, Adma Biologics (ADMA) could be a good stock pick from a technical perspective. ADMA surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

news source

Zacks Investment Research • Nov 6, 2026

news preview

ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call Transcript

ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 5, 2026

news preview

ADMA Biologics Q3 Earnings Call Highlights

ADMA Biologics NASDAQ: ADMA raised its minimum full-year earnings expectations after third-quarter profit rose on stronger sales of ASCENIV and improved manufacturing yields, even as competitive pressure weighed on its BIVIGAM product.

news source

MarketBeat • Nov 4, 2026

news preview

ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update

3Q 2026 Total Revenue of $141.1 Million, Increasing 5% Year-over-Year  3Q 2026 ASCENIV Revenue of $124.7 Million, Increasing 31% Year-over-Year 3Q 2026 GAAP Net Income of $49.9 Million, Increasing 37% Year-over-Year 3Q 2026 Adjusted Net Income ( 1) of $51.1 Million, Increasing 31% Year-over-Year 3Q 2026 GAAP Basic EPS of $0.22, Increasing 47% Year-over-Year  3Q 2026 Adjusted Basic EPS ( 2) of $0.23, Increasing 44% Year-over-Year  3Q 2026 Adjusted EBITDA ( 3 ) of $77.3 Million, Increasing 32% Year-over-Year 3Q 2026 Gross Margin of 71%, Expanding Approximately 1,450 Basis Points Year-over-Year Expanding ASCENIV Real-World Health Outcomes Evidence Strengthens Commercial Differentiation Robust Cash Generation, Operating Leverage and Share Repurchases Support Stockholder Value Encouraging Regulatory Feedback Received from SG-001 Pre-IND Meeting Package Reiterates FY2026 Revenue Guidance; Increases Adjusted Earnings Outlook RAMSEY, N.J. and BOCA RATON, Fla.

news source

GlobeNewsWire • Nov 4, 2026

news preview

Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates

Adma Biologics (ADMA) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.16 per share a year ago.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Adma Biologics (ADMA) stood at $11.41, denoting a -2.89% move from the preceding trading day.

news source

Zacks Investment Research • Oct 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in ADMA Biologics Inc

Open an M1 investment account to buy and sell ADMA Biologics Inc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ADMA on M1